Therapeutic Potential of Positive AMPA Receptor Modulators in the Treatment of Neuropsychiatric Disorders

This publication has 94 references indexed in Scilit:

• Facilitation of Task Performance and Removal of the Effects of Sleep Deprivation by an Ampakine (CX717) in Nonhuman Primates
  PLOS Biology, 2005
• Regionally selective and dose-dependent effects of the ampakines Org 26576 and Org 24448 on local cerebral glucose utilisation in the mouse as assessed by C-2-deoxyglucose autoradiography
  Neuropharmacology, 2005
• Association Analysis of Brain-Derived Neurotrophic Factor Val66Met Polymorphisms with Alzheimer’s Disease and Age of Onset
  Neuropsychobiology, 2004
• Identification of a Site in GluR1 and GluR2 That Is Important for Modulation of Deactivation and Desensitization
  Molecular Pharmacology, 2003
• The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function
  Cell, 2003
• Effects of 5′-Alkyl-Benzothiadiazides on (R,S)-α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Biophysics and Synaptic Responses
  Molecular Pharmacology, 2002
• A desensitization‐selective potentiator of AMPA‐type glutamate receptors
  British Journal of Pharmacology, 2002
• Reduced Cortical Synaptic Plasticity and GluR1 Expression Associated with Fragile X Mental Retardation Protein Deficiency
  Molecular and Cellular Neuroscience, 2002
• Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats
  Brain Research, 1996
• The Effects of Aniracetam (Ro 13–5057) on the Enhancement and Protection of Memory
  Annals of the New York Academy of Sciences, 1985